L-Asparaginase—Based Regimen in the Treatment of Refractory Midline Nasal/Nasal-Type T/NK-Cell Lymphoma
Authors:
- 1 August 2003
- journal article
- clinical trial
- Published by Springer Nature in International Journal of Hematology
- Vol. 78 (2) , 163-167
Abstract
Nasal, nasal-type T-cell/natural killer cell (T/NK-cell) lymphoma is a rare disease, and its prognosis is poor. Between March 1992 and March 2002 we investigated a new L-asparaginase-based salvage regimen to treat the disease and improve response to treatment and 5-year overall survival rate. Eighteen patients with refractory midline nasal, nasal-type T/NK-cell lymphoma, who were resistant to a cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP)-like regimen, received an L-asparaginase—based salvage regimen (L-asparaginase, vincristine, and dexamethasone). Primary involved field radiation was given to the patients after chemotherapy.Ten (55.6%) of the patients achieved complete response (CR). Five patients (27.8%) achieved partial response (PR).The overall response rate (CR + PR) was 83.3%.The 5-year overall survival rate was 55.6%. Results of the preliminary clinical study indicated that the L-asparaginase—based salvage regimen significantly improved the response rate and 5-year survival rate.The findings suggested that the therapy is a promising new salvage regimen for treating refractory midline nasal, nasal-type T/NK-cell lymphoma. Int J Hematol. 2003;78:163-167.Keywords
This publication has 22 references indexed in Scilit:
- Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modalityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- L-Asparaginase Induced Durable Remission of Relapsed Nasal NK/T-Cell Lymphoma After Autologous Peripheral Blood Stem Cell TransplantationInternational Journal of Hematology, 2001
- CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?Annals of Oncology, 2001
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- Introduction to the WHO ClassificationAmerican Journal of Surgical Pathology, 1997
- Epstein‐barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell typeInternational Journal of Cancer, 1995
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Reporting results of cancer treatmentCancer, 1981
- Radiation Therapy of Midline GranulomaAnnals of Internal Medicine, 1976